Multinational pharmaceutical group, MSD has been given planning approval for an expansion of its Carlow site. The new facility will create over 300 jobs.
Read more from Yala here Latest News
The permission given now has MSD aiming for completion of its facility in 2022 and will be the groups first manufacturing facility for vaccines outside of the US.
The facility will be a 13,000 sqm, the will additionally employ 170 permanent and 100 contractor staff to the site.
The construction phase of the facility is expected to involve over 700 construction staff. The Carlow site currently employees over 400 people in addition to it’s facilities in Dublin, Cork, Tipperary and Wicklow.